23 January 2024 - It’s a longstanding Government failure to never use federal “march-in” licensing rights to lower drug prices. It’s ...
22 January 2024 - In the fall of 2020, Robert Sachs was prescribed a medication to treat prostate cancer that had ...
18 January 2024 - Green light concerns generalised myasthenia gravis therapy ...
17 January 2024 - Lawmakers in Springfield are focusing on high prescription drug prices. ...
16 January 2024 - In 2023, EMA recommended 77 medicines for marketing authorisation. ...
8 January 2024 - We found that 491 novel orphan drugs were approved between 1990 and 2022. ...
8 January 2024 - Innovative drugs often mean new treatment options for patients and advances in health care for the American ...
2 January 2024 - The FDA’s Center for Drug Evaluation and Research approved 55 new drugs in 2023, as the small ...
2 January 2024 - In partnership with other global regulators, the international recognition procedure is expected to further help bring life-saving ...
28 December 2023 - US patients and drug makers will get a first glimpse of how much Medicare can negotiate down ...
19 December 2023 - Biogen today announced that the European Commission has revoked the centralised marketing authorizations for generic versions ...
18 December 2023 - The EMA and the Heads of Medicines Agencies have published an artificial intelligence workplan to 2028, ...
15 December 2023 - The Biden Administration said on Thursday it had identified 48 drugs in the Medicare program whose ...
13 December 2023 - CSL Behring has been granted Direct Access for Hemgenix (etranacogene dezaparvovec) by the French Ministry of ...
14 December 2023 - Apellis Pharmaceuticals announced today an update on the on-going review of its marketing authorisation application for ...